Related Experiment Video
Updated: Mar 22, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Hypoxic control of metastasis.
Erinn B Rankin1, Amato J Giaccia2
1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5152, USA. Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, CA 94305-5152, USA.
Hypoxia, a lack of oxygen in tumors, fuels cancer metastasis. Understanding hypoxia-inducible factors (HIFs) reveals new strategies to combat cancer spread and improve patient survival.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Metastatic disease is the primary cause of cancer mortality.
- Tumor microenvironment, particularly hypoxia, significantly drives cancer progression.
- Hypoxia-inducible factors (HIF-1 and HIF-2) are linked to increased metastasis and reduced survival across various cancers.
Purpose of the Study:
- To review the mechanisms by which the hypoxic tumor microenvironment promotes cancer metastasis.
- To identify potential biomarkers and therapeutic targets regulated by hypoxia.
Main Methods:
- Literature review of research on hypoxia and cancer metastasis.
- Analysis of studies investigating HIF signaling pathways in malignant cells.
Main Results:
- Hypoxia and HIF signaling critically influence multiple stages of the metastatic cascade.
- Specific biomarkers and therapeutic targets associated with hypoxia have been identified.
Conclusions:
- The hypoxic tumor microenvironment is a key driver of metastatic progression.
- Targeting hypoxia and HIF signaling presents a promising therapeutic avenue for preventing and treating metastatic disease.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

